7Baggers
 Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update  Defense World Fri, 03 Oct 2025 07:21:33 GMT
 Published on: 2025-10-03 01:35:13  newser.com Fri, 03 Oct 2025 06:35:13 GMT
 published on: 2025-09-28 02:09:36  newser.com Sun, 28 Sep 2025 07:09:36 GMT
 published on: 2025-09-22 10:05:14  newser.com Mon, 22 Sep 2025 15:05:14 GMT
 published on: 2025-09-22 00:30:59  newser.com Mon, 22 Sep 2025 05:30:59 GMT
 Published on: 2025-09-20 01:59:12  newser.com Sat, 20 Sep 2025 06:59:12 GMT
 published on: 2025-09-16 01:19:16  newser.com Tue, 16 Sep 2025 06:19:16 GMT
 published on: 2025-09-12 08:04:28  Newser Fri, 12 Sep 2025 13:04:28 GMT
 published on: 2025-09-10 23:51:19  Newser Thu, 11 Sep 2025 04:51:19 GMT
 published on: 2025-09-10 00:20:52  Newser Wed, 10 Sep 2025 05:20:52 GMT
 published on: 2025-09-09 04:05:33  Newser Tue, 09 Sep 2025 09:05:33 GMT
 published on: 2025-09-08 06:15:56  Newser Mon, 08 Sep 2025 11:15:56 GMT
 published on: 2025-09-08 06:03:07  Newser Mon, 08 Sep 2025 11:03:07 GMT
 published on: 2025-09-07 00:06:01  Newser Sun, 07 Sep 2025 05:06:01 GMT
 published on: 2025-09-03 23:14:46  Newser Thu, 04 Sep 2025 04:14:46 GMT
 published on: 2025-09-03 08:51:13  Newser Wed, 03 Sep 2025 13:51:13 GMT
 published on: 2025-09-02 14:31:30  Newser Tue, 02 Sep 2025 19:31:30 GMT
 published on: 2025-09-01 20:12:59  Newser Tue, 02 Sep 2025 01:12:59 GMT
 published on: 2025-08-31 17:25:58  Newser Sun, 31 Aug 2025 22:25:58 GMT

Adlai Nortye Ltd.
(NASDAQ:ANL) 

ANL stock logo

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent ...

Founded: 2004
IPO Price: $23 (Sep 29, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends